Clinical trial
Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration…
NCT00436995 · Amgen, Industry · Completed
Key facts
| NCT number | NCT00436995 |
|---|---|
| Title | Extension From Weekly to Once Every Other Week Darbepoetin Alfa Administration in Subjects With Chronic Kidney Disease Receiving Dialysis |
| Official title | A Multicentre, Single Arm Study Evaluating The Extension From Weekly To Once Every Other Week Darbepoetin Alfa Administration In Subjects With Chronic Kidney Disease Receiving Dialysis. |
| Lead sponsor | Amgen, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Kidney Disease |
| Intervention type | Drug |
| Interventions | Darbepoetin Alfa |
| Enrollment | 114 |
| Start date | Apr 1, 2006 |
| Primary completion | Jan 1, 2007 |
| Completion | Dec 1, 2008 |
| First posted | Feb 19, 2007 |
| Last update posted | Jan 21, 2011 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: